| P50 | author | Ege T. Kavalali | Q74886885 |
| | Lisa Marie Monteggia | Q83431583 |
| P2860 | cites work | Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals | Q22122053 |
| | Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 | Q22337290 |
| | Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex | Q24324026 |
| | Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome | Q24530286 |
| | Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation | Q24534159 |
| | Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice | Q24568049 |
| | The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome | Q24647294 |
| | FOXG1 is responsible for the congenital variant of Rett syndrome | Q24647431 |
| | MeCP2, a key contributor to neurological disease, activates and represses transcription | Q24647533 |
| | Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes | Q24670122 |
| | Dendritic anomalies in disorders associated with mental retardation | Q28139722 |
| | Identification of MeCP2 mutations in a series of females with autistic disorder | Q28207072 |
| | Epigenetic reprogramming in mammalian development | Q28212171 |
| | The story of Rett syndrome: from clinic to neurobiology | Q28256549 |
| | Mechanisms of disease: neurogenetics of MeCP2 deficiency | Q28260093 |
| | A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome | Q28504458 |
| | Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome | Q28505346 |
| | MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number | Q28507266 |
| | MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions | Q28511729 |
| | Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice | Q28513605 |
| | Covalent modification of DNA regulates memory formation | Q28576256 |
| | Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome | Q28587104 |
| | The transcriptional repressor Mecp2 regulates terminal neuronal differentiation | Q28588081 |
| | DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation | Q28591717 |
| | Derepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2 | Q28941210 |
| | Model of autism: increased ratio of excitation/inhibition in key neural systems | Q29547530 |
| | Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription | Q29547568 |
| | Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation | Q29616327 |
| | Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice | Q29616328 |
| | Reversal of neurological defects in a mouse model of Rett syndrome | Q29616452 |
| | Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3 | Q29616516 |
| | DNA methylation: past, present and future directions | Q31530974 |
| | Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation | Q33283941 |
| | Functional consequences of Rett syndrome mutations on human MeCP2. | Q33826022 |
| | Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. | Q33910551 |
| | Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males | Q34021143 |
| | A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases | Q34056069 |
| | Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. | Q34098728 |
| | Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations | Q34141668 |
| | Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots | Q34146268 |
| | Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain | Q34387585 |
| | Activity-dependent synaptogenesis in the adult Mammalian cortex | Q34921468 |
| | Expression of various genes is controlled by DNA methylation during mammalian development | Q35077698 |
| | Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein | Q35437213 |
| | CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms | Q35447640 |
| | Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. | Q35629499 |
| | MeCP2 dysfunction in humans and mice | Q36286542 |
| | Postmortem brain abnormalities of the glutamate neurotransmitter system in autism | Q38294784 |
| | Gene expression profiling in postmortem Rett Syndrome brain: differential gene expression and patient classification. | Q38295937 |
| | Transient cyclical methylation of promoter DNA. | Q40005345 |
| | Cyclical DNA methylation of a transcriptionally active promoter | Q40005351 |
| | Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. | Q40176354 |
| | DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. | Q40378884 |
| | Maintenance-type DNA methyltransferase is highly expressed in post-mitotic neurons and localized in the cytoplasmic compartment | Q40865405 |
| | Activity-dependent suppression of miniature neurotransmission through the regulation of DNA methylation. | Q42523444 |
| | The metabotropic glutamate receptor 8 gene at 7q31: partial duplication and possible association with autism | Q43074193 |
| | Spectrum of mutations in the MECP2 gene in patients with infantile autism and Rett syndrome | Q43076197 |
| | Dynamic expression of de novo DNA methyltransferases Dnmt3a and Dnmt3b in the central nervous system | Q45239531 |
| | Multiplex ligation-dependent probe amplification (MLPA) detects large deletions in the MECP2 gene of Swedish Rett syndrome patients | Q48000965 |
| | Expression of DNA methyltransferase gene in mature and immature neurons as well as proliferating cells in mice | Q48149199 |
| | Methyl-CpG-binding protein 2 is localized in the postsynaptic compartment: an immunochemical study of subcellular fractions. | Q48405918 |
| | Evidence that DNA (cytosine-5) methyltransferase regulates synaptic plasticity in the hippocampus. | Q48587952 |
| | MeCP2-dependent transcriptional repression regulates excitatory neurotransmission | Q48596466 |
| | Increased dendritic complexity and axonal length in cultured mouse cortical neurons overexpressing methyl-CpG-binding protein MeCP2. | Q48924208 |
| | DNA mismatch repair and DNA methylation in adult brain neurons. | Q49158568 |
| | Mutations found within exon 1 of MECP2 in Danish patients with Rett syndrome. | Q50542499 |
| | MECP2 mutation analysis in patients with mental retardation. | Q51935037 |
| | Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. | Q52087714 |
| | Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients. | Q52168328 |
| | The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse. | Q52202965 |
| | A 3 Mb deletion in 14q12 causes severe mental retardation, mild facial dysmorphisms and Rett-like features. | Q52588103 |
| | MECP2 mutations account for most cases of typical forms of Rett syndrome. | Q52922025 |
| | Dynamics of demethylation and activation of the alpha-actin gene in myoblasts | Q68636634 |
| | Prevalence of fragile X syndrome | Q71578926 |
| | Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA | Q73893290 |
| | MECP2 deletions and genotype-phenotype correlation in Rett syndrome | Q81517463 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Rett syndrome | Q917357 |
| P304 | page(s) | 204-210 | |
| P577 | publication date | 2008-12-05 | |
| P1433 | published in | Biological Psychiatry | Q4914961 |
| P1476 | title | Rett syndrome and the impact of MeCP2 associated transcriptional mechanisms on neurotransmission | |
| P478 | volume | 65 | |